Amgen will partner with Janssen Biotech to assess the drug combination made up of KYPROLIS, developed by Amgen, and DARZALEX, developed by Janssen, over the course of multiple clinical trials for the treatment of patients who have multiple myeloma. Read More »
Cigna is asking medical groups to join the effort of decreasing opioid use by 25 percent by signing a pledge to reduce opioid prescriptions and treat opioid abuse as a chronic condition. Read More »
The American Pharmacists Association recently released a video that commemorates its Pharmacy-based Immunization Certificate Training Program’s 20th anniversary. Read More »
According a new research study conducted by Visante, pharmacy benefit managers are saving consumers and payers $941 on average per person a year. Read More »
Rite Aid's Black Friday deals continue through the weekend. Read More »
RxGenomix's training program in Pharmacogenomics has been approved by the American Pharmacists Association as a continuing pharmacy education credit. Read More »
Neovacs will partner with 3P Biopharmaceuticals to manufacture interferon alpha following its purchase of technology from AMEGABIOTECH. Read More »
Eli Lilly and Co.'s EXPEDITION3 clinical study involving solanezumab failed to meet its primary goal in treating Alzheimer’s. Read More »
Novo Nordisk's Changing Diabetes in Children program has received a four-year extension to provide access to diabetes care and free insulin to children in developing countries who have Type 1 diabetes. Read More »
Merck has released new data involving KEYTRUDA, Merck’s anti-PD-1 therapy designed for the treatment of a number of blood cancers, and its investigational use. Read More »
Mallinckrodt's Phase 2 clinical study involving H.P. Acthar Gel to evaluate the effectiveness of the medication on patients who have Amytropic Lateral Sclerosis will begin in 2017. Read More »
CVS Pharmacy's Black Friday sales event will give its ExtraCare members the opportunity to save. Read More »
Arrowhead Pharmaceuticals has closed the license and collaboration agreement with Amgen regarding the RNAi ARC-LPA program. Read More »
Kmart Pharmacy has added Medicare Part D and its members can now use Kmart Pharmacy for their pharmaceutical needs in 2017 as their preferred provider. Read More »
Agios Pharmaceuticals recently presented the first data from its Phase 1 AG-120 study dose expansion cohorts at the Society for Neuro-Oncology annual meeting. Read More »
The Academy of Managed Care Pharmacy recently hosted a national health care forum about value and outcomes in oncology where the key topics of conversation revolved around the fast-growing innovations in oncology and how complex cancer treatments have become. Read More »
Novocure's long-term data results of its Phase 3 EF-14 trial involving Optune combined with temozolomide are consistent with the results from the interim analysis of the data. Read More »
Celgene Corp. has purchased Triphase Accelerator Corp.'s assets regarding its proteasome inhibitor, marizomib, which is being developed for the treatment of glioblastoma and relapsed and/or refractory multiple myeloma. Read More »
Merck KGaA's businesses in Massachusetts have been ranked among the “Top Places to Work” by The Boston Globe. Read More »
Amgen's addition of RepathaA (evolocumab) to optimized statin therapy has resulted in a noteworthy statistical decrease of atherosclerosis in patients who have coronary artery disease. Read More »
Alerts Sign-up
